300683 海特生物
已收盘 03-13 15:00:00
资讯
新帖
简况
海特生物：公司注射用埃普奈明2023年11月获批上市，2024年开始销售，2025年被纳入国家医保目录，目前销售顺利，符合公司预期
证券之星 · 03-13 20:51
海特生物：公司注射用埃普奈明2023年11月获批上市，2024年开始销售，2025年被纳入国家医保目录，目前销售顺利，符合公司预期
海特生物(300683)3月10日股东户数1.8万户，较上期增加7.71%
证券之星 · 03-13 17:18
海特生物(300683)3月10日股东户数1.8万户，较上期增加7.71%
海特生物：公司中间体、原料药业务近两年因市场竞争加剧，订单不足，目前是公司主要亏损源
每日经济新闻 · 03-13 12:44
海特生物：公司中间体、原料药业务近两年因市场竞争加剧，订单不足，目前是公司主要亏损源
海特生物：截止3月10日，公司股东人数为17,968户
证券之星 · 03-12 11:36
海特生物：截止3月10日，公司股东人数为17,968户
股市必读：海特生物(300683)股东户数1.67万户，较上期减少1.23%
证券之星 · 03-09
股市必读：海特生物(300683)股东户数1.67万户，较上期减少1.23%
海特生物：截止2月27日，公司股东人数为16,682户
证券之星 · 03-06
海特生物：截止2月27日，公司股东人数为16,682户
海特生物(300683)2月27日股东户数1.67万户，较上期减少1.23%
证券之星 · 03-04
海特生物(300683)2月27日股东户数1.67万户，较上期减少1.23%
海特生物：截止2月27日，公司股东人数为16,682户
证券之星 · 03-03
海特生物：截止2月27日，公司股东人数为16,682户
股市必读：海特生物(300683)股东户数1.81万户，较上期减少6.51%
证券之星 · 02-24
股市必读：海特生物(300683)股东户数1.81万户，较上期减少6.51%
海特生物：截止2026年2月10日，公司股东人数为18,142户
证券之星 · 02-13
海特生物：截止2026年2月10日，公司股东人数为18,142户
新版基药目录管理办法公布；“减肥神药”或能改善骨关节炎
21世纪经济报道 · 02-12
新版基药目录管理办法公布；“减肥神药”或能改善骨关节炎
海特生物最新公告：拟6201.90万元收购北京沙东23.08%股权
证券之星 · 02-11
海特生物最新公告：拟6201.90万元收购北京沙东23.08%股权
海特生物：截止2026年1月30日，公司股东人数为19,406户
证券之星 · 02-11
海特生物：截止2026年1月30日，公司股东人数为19,406户
海特生物（300683）披露2026年第一次临时股东会决议公告，2月5日股价下跌1.25%
证券之星 · 02-05
海特生物（300683）披露2026年第一次临时股东会决议公告，2月5日股价下跌1.25%
股市必读：海特生物（300683）1月28日董秘有最新回复
证券之星 · 01-29
股市必读：海特生物（300683）1月28日董秘有最新回复
海特生物：该会议为注射用埃普奈明新增软骨肉瘤新适应症preIND的沟通交流会议申请
证券之星 · 01-28
海特生物：该会议为注射用埃普奈明新增软骨肉瘤新适应症preIND的沟通交流会议申请
海特生物：预计2025年全年营业收入4.82亿元至5.87亿元
证券之星 · 01-23
海特生物：预计2025年全年营业收入4.82亿元至5.87亿元
股市必读：海特生物（300683）1月22日董秘有最新回复
证券之星 · 01-23
股市必读：海特生物（300683）1月22日董秘有最新回复
海特生物：截至1月20日股东人数为19,743户
证券之星 · 01-21
海特生物：截至1月20日股东人数为19,743户
“A+H”组合有魔法，海特生物筹划港股上市
支点财经 · 01-21
“A+H”组合有魔法，海特生物筹划港股上市
公司概况
公司名称：
武汉海特生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-08-08
主营业务：
武汉海特生物制药股份有限公司的主营业务是大分子生物药、小分子化学药、原料药与医药中间体的生产销售，同时也为国内外的制药企业提供制剂和原料药的CRO、CMO和CDMO技术服务。公司的主要产品是神经损伤修复类药物、治疗用生物制品、化学药物、药学研究、CRO临床业务。报告期内，公司荣获“2024年度中国车谷经济高质量发展企业”称号、公司的“注射用鼠神经生长因子”、“注射用埃普奈明”两个产品被列入《湖北省创新产品应用示范推荐目录》（2024年版）。
发行价格：
32.94
{"stockData":{"symbol":"300683","market":"SZ","secType":"STK","nameCN":"海特生物","latestPrice":34.46,"timestamp":1773385386000,"preClose":37.91,"halted":0,"volume":10818700,"delay":0,"changeRate":-0.091,"floatShares":122000000,"shares":131000000,"eps":-1.434,"marketStatus":"已收盘","change":-3.45,"latestTime":"03-13 15:00:00","open":37.91,"high":38,"low":34.4,"amount":381000000,"amplitude":0.095,"askPrice":34.47,"askSize":24,"bidPrice":34.46,"bidSize":428,"shortable":0,"etf":0,"ttmEps":-1.434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":5,"adr":0,"adjPreClose":37.91,"symbolType":"stock","openAndCloseTimeList":[[1773365400000,1773372600000],[1773378000000,1773385200000]],"highLimit":41.7,"lowLimit":34.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":130894391,"isCdr":false,"pbRate":2.22,"roa":"--","roe":"--","epsLYR":-0.53,"committee":0.703959,"marketValue":4511000000,"turnoverRate":0.0886,"status":1,"floatMarketCap":4206000000},"requestUrl":"/m/hq/s/300683/wiki","defaultTab":"wiki","newsList":[{"id":"2619700197","title":"海特生物：公司注射用埃普奈明2023年11月获批上市，2024年开始销售，2025年被纳入国家医保目录，目前销售顺利，符合公司预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619700197","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619700197?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:51","pubTimestamp":1773406317,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)03月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好。注射用埃普奈明（沙艾特）销售有一年了，请问目前市场反馈如何？海特生物回复：尊敬的投资者，你好。公司注射用埃普奈明2023年11月获批上市，2024年开始销售，2025年被纳入国家医保目录，目前销售顺利，符合公司预期。具体情况可关注公司的定期报告。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300038437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2619604061","title":"海特生物(300683)3月10日股东户数1.8万户，较上期增加7.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619604061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619604061?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:18","pubTimestamp":1773393515,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海特生物披露，截至2026年3月10日公司股东户数为1.8万户，较2月27日增加1286.0户，增幅为7.71%。在医疗服务行业个股中，海特生物股东户数低于行业平均水平，截至3月10日，医疗服务行业平均股东户数为4.56万户。从股价来看，2026年2月27日至2026年3月10日，海特生物区间涨幅为10.82%，在此期间股东户数增加1286.0户，增幅为7.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2619375168","title":"海特生物：公司中间体、原料药业务近两年因市场竞争加剧，订单不足，目前是公司主要亏损源","url":"https://stock-news.laohu8.com/highlight/detail?id=2619375168","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619375168?lang=zh_cn&edition=full","pubTime":"2026-03-13 12:44","pubTimestamp":1773377040,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：公司中间体、原料药业务目前市场竞争激烈吗？还有价格战吗？能达到盈亏平衡吗？海特生物（300683.SZ）3月13日在投资者互动平台表示，公司中间体、原料药业务近两年因市场竞争加剧，订单不足，目前是公司主要亏损源。公司正在积极推进该业务的发展，已做一些技术、产品储备，努力实现该业务的减亏及扭亏。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-13/doc-inhqvhtr7926458.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-13/doc-inhqvhtr7926458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2618909089","title":"海特生物：截止3月10日，公司股东人数为17,968户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618909089?lang=zh_cn&edition=full","pubTime":"2026-03-12 11:36","pubTimestamp":1773286600,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问公司26年3月10日股东户数是多少？谢谢！海特生物回复：尊敬的投资者，您好。截止3月10日，公司股东人数为17,968户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200016162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2618695551","title":"股市必读：海特生物(300683)股东户数1.67万户，较上期减少1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618695551","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618695551?lang=zh_cn&edition=full","pubTime":"2026-03-09 01:43","pubTimestamp":1772991791,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，海特生物报收于32.41元，上涨4.45%，换手率3.74%，成交量4.56万手，成交额1.46亿元。来自股本股东变化：截至2026年2月27日股东户数环比下降1.23%，户均持股上升至7846.0股，筹码集中度有所提高。股本股东变化股东户数变动近日海特生物披露，截至2026年2月27日公司股东户数为1.67万户，较2月13日减少207.0户，减幅为1.23%。户均持股数量由上期的7750.0股增加至7846.0股，户均持股市值为26.25万元。截止2月27日，公司股东人数为16,682户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900000766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2617507050","title":"海特生物：截止2月27日，公司股东人数为16,682户","url":"https://stock-news.laohu8.com/highlight/detail?id=2617507050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617507050?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:06","pubTimestamp":1772780778,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问公司2/27号股东户数是多少？谢谢！海特生物回复：尊敬的投资者，您好。截止2月27日，公司股东人数为16,682户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600018720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2616336495","title":"海特生物(300683)2月27日股东户数1.67万户，较上期减少1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616336495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616336495?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:12","pubTimestamp":1772615540,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海特生物披露，截至2026年2月27日公司股东户数为1.67万户，较2月13日减少207.0户，减幅为1.23%。在医疗服务行业个股中，海特生物股东户数低于行业平均水平，截至2月27日，医疗服务行业平均股东户数为4.57万户。从股价来看，2026年2月13日至2026年2月27日，海特生物区间涨幅为4.69%，在此期间股东户数减少207.0户，减幅为1.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400029841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2616935733","title":"海特生物：截止2月27日，公司股东人数为16,682户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616935733","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616935733?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:52","pubTimestamp":1772499131,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：截止2月26号，公司股东户数是多少？谢谢海特生物回复：尊敬的投资者，您好。截止2月27日，公司股东人数为16,682户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300007082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2613213736","title":"股市必读：海特生物(300683)股东户数1.81万户，较上期减少6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613213736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613213736?lang=zh_cn&edition=full","pubTime":"2026-02-24 01:27","pubTimestamp":1771867628,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，海特生物报收于31.96元，下跌2.29%，换手率3.41%，成交量4.16万手，成交额1.34亿元。交易信息汇总资金流向2月13日主力资金净流出1211.24万元，占总成交额9.03%；游资资金净流出725.34万元，占总成交额5.41%；散户资金净流入1936.59万元，占总成交额14.44%。股本股东变化股东户数变动近日海特生物披露，截至2026年2月10日公司股东户数为1.81万户，较1月30日减少1264.0户，减幅为6.51%。户均持股数量由上期的6745.0股增加至7215.0股，户均持股市值为24.88万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400007125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2611190243","title":"海特生物：截止2026年2月10日，公司股东人数为18,142户","url":"https://stock-news.laohu8.com/highlight/detail?id=2611190243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611190243?lang=zh_cn&edition=full","pubTime":"2026-02-13 09:01","pubTimestamp":1770944470,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问公司2/10号股东户数是多少？谢谢！海特生物回复：您好，感谢您的关注。截止2026年2月10日，公司股东人数为18,142户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300006431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2610960339","title":"新版基药目录管理办法公布；“减肥神药”或能改善骨关节炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960339","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610960339?lang=zh_cn&edition=full","pubTime":"2026-02-12 07:27","pubTimestamp":1770852424,"startTime":"0","endTime":"0","summary":"这里是《21健讯Daily》，欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件！政策动向国家卫健委等11部门联合印发《国家基本药物目录管理办法》2月11日，国家卫生健康委等联合印发《国家基本药物目录管理办法》。与原有的文件相比，《国家基本药物目录管理办法》主要修订六个方面：一是增加法律政策依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602123648366353.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602123648366353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828474.EUR","BK0028","BK0183","BK0099","LU2097828714.EUR","BK0077","BK0046","LU2580892789.USD","LU0405327148.USD","BK0239","LU1781817850.SGD","LU2097828557.USD","LU1064131003.USD","BK0187","BK0209","LU1969619763.USD","LU2097828805.USD","LU2148510915.USD","LU2580892862.HKD","BK0020","LU1328615791.USD","LU1997244956.HKD","LU2097828631.EUR","BK0184","LU1997245094.SGD","LU1064130708.USD","BK0060","BK0175","LU1580142542.USD","LU2488822045.USD","601607","LU1146622755.USD","LU2328871848.SGD","BK0070","LU1997245177.USD","LU1655091616.SGD","301075","LU0405327494.USD","BK0188","LU1820825898.SGD","LU2495084118.USD","300683","BK0012","LU1255011170.USD","LU2289578879.USD","BK0196","300142","BK0097","600276"],"gpt_icon":0},{"id":"2610982912","title":"海特生物最新公告：拟6201.90万元收购北京沙东23.08%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610982912","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610982912?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:37","pubTimestamp":1770799028,"startTime":"0","endTime":"0","summary":"海特生物(300683.SZ)公告称，公司根据已签订的《股权收购协议书》，拟使用自有资金6201.90万元受让君和企业有限公司、朱冬梅、杨世方、崔俊生、SHA BINGDONG、蔚坷利合计持有的北京沙东23.0816%的股权。交易完成后，公司将持有北京沙东98.8420%的股权。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100026033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2610960391","title":"海特生物：截止2026年1月30日，公司股东人数为19,406户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960391","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610960391?lang=zh_cn&edition=full","pubTime":"2026-02-11 09:12","pubTimestamp":1770772326,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)02月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月31日公司股东人数是多少？谢谢海特生物回复：您好，感谢您的关注。截止2026年1月30日，公司股东人数为19,406户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100006441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2609856309","title":"海特生物（300683）披露2026年第一次临时股东会决议公告，2月5日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609856309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609856309?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:16","pubTimestamp":1770300977,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，海特生物报收于32.31元，较前一交易日下跌1.25%，最新总市值为42.29亿元。该股当日开盘32.5元，最高32.93元，最低32.01元，成交额达2.48亿元，换手率为6.27%。公司于近日发布《2026年第一次临时股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2607474933","title":"股市必读：海特生物（300683）1月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607474933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607474933?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:31","pubTimestamp":1769621470,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，海特生物报收于31.31元，下跌3.6%，换手率5.81%，成交量7.09万手，成交额2.25亿元。董秘最新回复投资者： 请问当前沙艾特入院数量和月均处方量是多少，千万别回等公告披露，谢谢；董秘： 您好，感谢您的关注。关于沙艾特的具体情况请查看公司的定期报告，以公司公告为准。当日关注点来自交易信息汇总：1月28日主力资金净流出1777.18万元，散户资金净流入2840.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900000947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2606881766","title":"海特生物：该会议为注射用埃普奈明新增软骨肉瘤新适应症preIND的沟通交流会议申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2606881766","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606881766?lang=zh_cn&edition=full","pubTime":"2026-01-28 11:30","pubTimestamp":1769571033,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司在CDE申请的会议（申请编号：2025006893，会议类型：II类）具体是关于什么内容的，谢谢！海特生物回复：尊敬的投资者，您好！该会议为注射用埃普奈明新增软骨肉瘤新适应症preIND的沟通交流会议申请。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800016555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2605032214","title":"海特生物：预计2025年全年营业收入4.82亿元至5.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605032214","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605032214?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:01","pubTimestamp":1769176877,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物发布业绩预告，预计2025年全年营业收入4.82亿元至5.87亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300042160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683"],"gpt_icon":0},{"id":"2605416579","title":"股市必读：海特生物（300683）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416579?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:23","pubTimestamp":1769102595,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，海特生物报收于30.94元，上涨4.28%，换手率9.83%，成交量12.0万手，成交额3.6亿元。董秘最新回复投资者： 董秘您好，请问公司到1月20日的股东人数，谢谢董秘： 您好，感谢您的关注。截止2026年1月20日，公司股东人数为19,743户。当日关注点来自交易信息汇总：1月22日主力资金净流入1686.26万元，显示主力对个股关注度提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2605175000","title":"海特生物：截至1月20日股东人数为19,743户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605175000","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605175000?lang=zh_cn&edition=full","pubTime":"2026-01-21 15:12","pubTimestamp":1768979532,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至1月20日收盘公司股东人数是多少？谢谢！海特生物回复：您好，感谢您的关注。截止2026年1月20日，公司股东人数为19,743户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100019465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2605207211","title":"“A+H”组合有魔法，海特生物筹划港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2605207211","media":"支点财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605207211?lang=zh_cn&edition=full","pubTime":"2026-01-21 13:29","pubTimestamp":1768973340,"startTime":"0","endTime":"0","summary":"1月20日，武汉海特生物制药股份有限公司（以下简称“海特生物”，300683.SZ)发布公告称，公司拟申请在香港联交所主板挂牌上市。海特生物表示，此举是为进一步提高公司综合竞争力，提升公司 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260121/c674185799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0239","300683"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773452457620,"stockEarnings":[{"period":"1week","weight":0.0633},{"period":"1month","weight":0.0348},{"period":"3month","weight":0.2083},{"period":"6month","weight":-0.1692},{"period":"1year","weight":0.4187},{"period":"ytd","weight":0.2427}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0088},{"period":"3month","weight":0.053},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.2193},{"period":"ytd","weight":0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉海特生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17968人(较上一季度增加7.71%)","perCapita":"6793股","listingDate":"2017-08-08","address":"湖北省武汉市蔡甸区经济技术开发区海特科技园","registeredCapital":"13089万元","survey":" 武汉海特生物制药股份有限公司的主营业务是大分子生物药、小分子化学药、原料药与医药中间体的生产销售，同时也为国内外的制药企业提供制剂和原料药的CRO、CMO和CDMO技术服务。公司的主要产品是神经损伤修复类药物、治疗用生物制品、化学药物、药学研究、CRO临床业务。报告期内，公司荣获“2024年度中国车谷经济高质量发展企业”称号、公司的“注射用鼠神经生长因子”、“注射用埃普奈明”两个产品被列入《湖北省创新产品应用示范推荐目录》（2024年版）。","listedPrice":32.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海特生物(300683)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海特生物(300683)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海特生物,300683,海特生物股票,海特生物股票老虎,海特生物股票老虎国际,海特生物行情,海特生物股票行情,海特生物股价,海特生物股市,海特生物股票价格,海特生物股票交易,海特生物股票购买,海特生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海特生物(300683)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海特生物(300683)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}